GL1X · GenesisL1 explorer

Research workbench

HIV-rt with non-nucleoside inhibitor annulated pyrazole 2

Analyse HIV-rt with non-nucleoside inhibitor annulated pyrazole 2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3E01
Type
protein
Length
953 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Gag-pol polyprotein
EC
2.7.7.49, 2.7.7.7, 3.1.26.4
UniProt
P04585
Ligands
PZ2
Pockets
16 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGag-pol polyprotein (EC 2.7.7.49, 2.7.7.7, 3.1.26.4)protein55232% helix, 22% strandP04585
BGag-pol polyprotein (EC 2.7.7.49, 2.7.7.7, 3.1.26.4)protein40139% helix, 18% strandP04585

Ligands and binding sites

  • PZ2 · 3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19120.800.8295PZ2
22630.700.8540empty
33790.700.8231empty
42070.550.7932empty
5810.500.8319empty

Interfaces

1 interface between chains.

  • A–B · 2962 Ų buried · 30 hydrogen bonds · protein-protein

Compared structures

  • 3E01 · HIV-RT with non-nucleoside inhibitor annulated pyrazole 2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.